Source: Business Wire

Press Release: Algorithm Pharma : Third iCardiac/ERT-Certified Site for Altasciences Clinical Research

LAVAL, Quebec--(BUSINESS WIRE)--#FIH--Altasciences Clinical Research announced today that its third clinical facility, Algorithme Pharma USA, in Fargo, North Dakota, has received its iCardiac/ERT Certification. Altasciences' experience using High Precision QT analysis allows us to perform thorough QT (TQT) prolongation studies with a smaller number of participants due to the reduced variability using the iCardiac/ERT technique. Also, Altasciences offers High Precision QT analysis to assess QT prolong

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Christopher Perkin's photo - President & CEO of Algorithme Pharma

President & CEO

Christopher Perkin

CEO Approval Rating

70/100

Read more